OPT ASX News

18 September 2024

New!
Opthea Announces Completion of Drug Substance Campaign

Opthea finalizes drug substance PPQ campaign for sozinibercept.

Opthea Sozinibercept Biopharmaceutical Wet AMD Stock Market News

Posted on: 18/09/2024

Read More

31 July 2024

Quarterly Activities/Appendix 4C Cash Flow Report

Opthea completes pivotal trial enrolment and raises A$227.3m for wet AMD drug development.

Opthea Wet AMD Clinical Trials Biopharmaceutical Stock Market News

Posted on: 31/07/2024

Read More